Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

NCT00716053 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Upper Lobe Predominant Emphysema

Interventions

DRUG: BLVR

Sponsor

Aeris Therapeutics